David Perlman, MD Email David Perlman
- PROFESSOR | Medicine, Infectious Diseases
- Infectious Disease
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai Union Square 212-844-8549 212-844-8549
Book an Appointment - David Perlman, MD
He has over 20 years’ experience in HIV, HCV and related in substance using population and remains active as a clinician in these areas. He has served as principal investigator on multi-center trials within NIAID’s AIDS Clinical Trials group, and on R01 grants from NIDA. He has served on NIH study sections, CDC consensus panels, committees within the ACTG and the NYS DOH AIDS Institute, and the Planning Committee of the NYCDOMH New York Hepatitis C Research Consortium. He is the Director, Infectious Diseases Core, in the NIDA-funded multi-institutional P30 Center for Drug Use and HIV Research (CDUHR) where his role is to facilitate multi-disciplinary interactions and research among biomedical and socio-behavioral scientists.
He is an active clinician, doing inpatient consultative infectious diseases and a full range of office infectious diseases.
American Board of Internal Medicine
- HIV Testing And Treatment Program
- HIV and AIDS
- Hepatitis A Vaccine
- Hepatitis B
- Hepatitis B Vaccine
- Hepatitis C
- Japanese Encephalitis Vaccine
- Meningococcal Vaccine
- Polio Vaccine
- Rabies Vaccine
- Tetanus Vaccine
- Travel Medicine
- Traveler's Diarrhea
- Typhoid Vaccine
- Varicella Vaccine
- Yellow Fever Vaccine
Addiction, Biomedical Sciences, Epidemiology, Global Health, HIV/AIDS, Hepatitis C Virus, Infectious Disease
MD, Albert Einstein College of Medicine
BA, Dartmouth College
Residency, Internal Medicine
Memorial Sloan-Kettering Cancer Center
Fellowship, Infectious Disease
Albert Einstein College of Medicine
Best Doctors 2012, 2013, 2014, 2016, 2017 & 2018
President, Infectious Diseases Society of New York
TB Committee, Infectious Disease Society of
Fellow, Infectious Disease Society of America
College on Problems of Drug Dependence
The Leo M. Davidoff Society - for excellence in teaching
Super Doctors 2014, 2015, 2017 & 2019
His earlier work focused on studies of the epidemiology of tuberculosis among drug users, and on health care delivery models and behavioral and structural interventions to facilitate adherence to the TB care continuum. Recent work has focused on the delivery of other health care services (HIV, STI, HCV, HBV, others) to drug users in and out of drug abuse treatment, a qualitative and quantitative study of barriers and facilitators of HIV and HCV testing and care among ethnic minority drug users, and a “seek, test, treat and retain” intervention for high risk heterosexuals. A prominent line of inquiry has been improving adherence to multi-step heath care interventions and care continua in a variety of settings, including extensive work with drug using populations in and out of drug abuse treatment settings. His current work focuses on the HCV care continuum. He was PI of the NIDA funded “Bridges” project, an RCT of a combined case management-motivational interviewing intervention to promote adherence to off-site referral for HCV care from methadone maintenance treatment (published in AJPH and selected for the AHRQ New Innovations Exchange). He is actively involved in a number of ongoing projects.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Perlman did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.